Repligen Corp (RGEN) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $167.49 +1.08%
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Repligen Corp (NASDAQ: RGEN) reported Q2 EPS of $0.02, $0.04 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $8.63 million versus the consensus estimate of $7.5 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
Earnings, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
